FindTrial
Sign In

Prognostic Factors Predicting the Development of Drug Reaction with Eosinophilia and Systemic Symptoms in Patients Presenting with Maculopapular Exanthems

Prognostic Factors Predicting the Development of Drug Reaction with Eosinophilia and Systemic Symptoms in Patients Presenting with Maculopapular Exanthems

Status
Unknown
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20240615002
Enrollment
40
Registered
2024-06-15
Start date
2023-09-28
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients who suspected drug-induced MP rash. DRESS syndrome, drug rash

Interventions

Patients who were suspected Drug-induced MP rash with RegiSCAR less than 4,Patients who were suspected Drug-induced MP rash with RegiSCAR equal to or more than 4
Diagnostic,Diagnostic
Minor drug rash,probable or definite DRESS

Sponsors

Faculty of Medicine, Chulalongkorn University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age more than 18 years old. 2. Patients who suspected to have diagnosed with drug-induced maculopapular exanthem.

Exclusion criteria

Exclusion criteria: 1. Toxic epidermal necrosis (TEN) and Stevens-Johnson Syndrome (SJS) 2. Thromboembolism 3. Pregnancy 4. Anticoagulant usage 5. Active malignancy 6. Recent trauma or surgery within 1 month 7. Vitamin B12 supplement usage

Design outcomes

Primary

MeasureTime frame
Vitamin B12, Procalcitonin, d-dimer at the dat of admission, day 3, day 7 blood sample levels—

Secondary

MeasureTime frame
CBC, LFT, BUN,Cr at the day of admission, day 3, day 7 blood sample levels—

Countries

Thailand

Contacts

Public ContactNatasorn Lekuthai

Faculty of Medicine , Chulalongkorn University

natasorn.lek@gmail.com0824264266

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026